104 related articles for article (PubMed ID: 27695347)
1. Clinical comparative investigation of efficacy and toxicity of cisplatin plus gemcitabine or plus Abraxane as first-line chemotherapy for stage III/IV non-small-cell lung cancer.
Ai D; Guan Y; Liu XJ; Zhang CF; Wang P; Liang HL; Guo QS
Onco Targets Ther; 2016; 9():5693-5698. PubMed ID: 27695347
[TBL] [Abstract][Full Text] [Related]
2. Clinical investigation of efficacy of albumin bound paclitaxel plus platinum compounds as first-line chemotherapy for stage III/IV squamous non-small cell lung cancer.
Fang Y; Wang L; Xia GH; Shi MQ
Asian Pac J Cancer Prev; 2014; 15(17):7453-7. PubMed ID: 25227858
[TBL] [Abstract][Full Text] [Related]
3. Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial.
Vrankar M; Zwitter M; Bavcar T; Milic A; Kovac V
Radiol Oncol; 2014 Dec; 48(4):369-80. PubMed ID: 25435850
[TBL] [Abstract][Full Text] [Related]
4. Nab-paclitaxel (abraxane)-based chemotherapy to treat elderly patients with advanced non-small-cell lung cancer: a single center, randomized and open-label clinical trial.
Chen H; Huang X; Wang S; Zheng X; Lin J; Li P; Lin L
Chin J Cancer Res; 2015 Apr; 27(2):190-6. PubMed ID: 25937781
[TBL] [Abstract][Full Text] [Related]
5. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial.
Thatcher N; Hirsch FR; Luft AV; Szczesna A; Ciuleanu TE; Dediu M; Ramlau R; Galiulin RK; Bálint B; Losonczy G; Kazarnowicz A; Park K; Schumann C; Reck M; Depenbrock H; Nanda S; Kruljac-Letunic A; Kurek R; Paz-Ares L; Socinski MA;
Lancet Oncol; 2015 Jul; 16(7):763-74. PubMed ID: 26045340
[TBL] [Abstract][Full Text] [Related]
6. [A randomized clinical trial of gemcitabine plus cisplatin compared with gemcitabine plus vinorelbine in the treatment of non-small cell lung cancer].
Zhang L; Li N; Xu F; Zhang Y
Zhongguo Fei Ai Za Zhi; 2005 Dec; 8(6):530-4. PubMed ID: 21208543
[TBL] [Abstract][Full Text] [Related]
7. Prolonged progression-free survival achieved by gemcitabine, cisplatin, and albumin-bound paclitaxel for the treatment of advanced biliary tract cancers.
Choi JH; Park H; Park JK; Lee JK; Lee KT; Lee KH
Ther Adv Med Oncol; 2024; 16():17588359231225045. PubMed ID: 38249335
[TBL] [Abstract][Full Text] [Related]
8. [Randomized clinical trial of paclitaxel plus cisplatin versus gemcitabine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer].
Gou H; Chen X; Hou M; Yang Y
Zhongguo Fei Ai Za Zhi; 2007 Apr; 10(2):141-3. PubMed ID: 21114939
[TBL] [Abstract][Full Text] [Related]
9. Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG).
Kentepozidis N; Economopoulou P; Christofyllakis C; Chelis L; Polyzos A; Vardakis N; Koinis F; Vamvakas L; Katsaounis P; Kalbakis K; Nikolaou C; Georgoulias V; Kotsakis A
Clin Transl Oncol; 2017 Mar; 19(3):317-325. PubMed ID: 27492015
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study on gemcitabine plus cisplatin and vinorelbine plus ifosfamide plus cisplatin combined chemotherapy in the treatment of advanced non-small cell lung cancer].
Zhao Y; Chen Y; Ji H; Chu T; Han B; Liao M
Zhongguo Fei Ai Za Zhi; 2004 Oct; 7(5):449-51. PubMed ID: 21244803
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of S-1 plus cisplatin combined with bevacizumab for advanced non-squamous non-small cell lung cancer (TCOG LC-1202).
Miyanaga A; Kubota K; Hosomi Y; Okuma Y; Minato K; Fujimoto S; Okamoto H; Satouchi M; Isobe H; Aono H; Takiguchi Y; Gemma A;
Jpn J Clin Oncol; 2019 Aug; 49(8):749-754. PubMed ID: 31070750
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysis.
Choi JH; Oh SY; Kwon HC; Kim JH; Lee JH; Lee S; Lee DM; Kim SH; Rho MH; Kim YH; Rho MS; Kim HJ
Cancer Res Treat; 2008 Mar; 40(1):22-6. PubMed ID: 19688061
[TBL] [Abstract][Full Text] [Related]
13. [Randomized clinical study comparing gemcitabine and oxaliplatin versus gemcitabine and cisplatin for advanced non-small cell lung cancer in elderly patients].
Sun Q; Hua J; Hang X; Mao Y; Wang Q
Zhongguo Fei Ai Za Zhi; 2005 Oct; 8(5):451-3. PubMed ID: 21205532
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.
Ikeda S; Kato T; Ogura T; Sekine A; Oda T; Masuda N; Igawa S; Katono K; Otani S; Yamada K; Saito H; Kondo T; Hosomi Y; Nakahara Y; Nishikawa M; Utumi K; Misumi Y; Yamanaka T; Sakamaki K; Okamoto H
BMC Cancer; 2018 Mar; 18(1):241. PubMed ID: 29499653
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer].
Li N; Jin ZL; Liu ZJ; Wang J; Li K
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):937-42. PubMed ID: 22340106
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness of pemetrexed combined with cisplatin chemotherapy for advanced and maintenance treatment for patients with non-small-cell lung cancer.
Zhu YM; Gan YL; Xu HY; Chen WH; Dai HP
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1943-1947. PubMed ID: 29687847
[TBL] [Abstract][Full Text] [Related]
17. Association of losartan with outcomes in metastatic pancreatic cancer patients treated with chemotherapy.
Kasi A; Allen J; Mehta K; Dandawate P; Saha S; Bossmann S; Anant S; Sun W
J Clin Transl Res; 2021 Apr; 7(2):257-262. PubMed ID: 34104829
[TBL] [Abstract][Full Text] [Related]
18. Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer.
Koba T; Minami S; Nishijima-Futami Y; Masuhiro K; Kimura H; Futami S; Yaga M; Mori M; Kagawa H; Uenami T; Kohmo S; Otsuka T; Yamamoto S; Komuta K; Kijima T
Cancer Chemother Pharmacol; 2018 Jul; 82(1):111-117. PubMed ID: 29728800
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study of navelbine combined with cisplatin in the treatment of advanced non-small cell lung cancer].
He Y
Zhongguo Fei Ai Za Zhi; 2004 Dec; 7(6):517-9. PubMed ID: 21251412
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of Aidi injection plus paclitaxel-based chemotherapy for advanced non-small cell lung cancer: A meta-analysis of 31 randomized controlled trials following the PRISMA guidelines.
Xiao Z; Wang C; Zhou M; Hu S; Jiang Y; Huang X; Li N; Feng J; Tang F; Chen X; Ding J; Chen L; Wang Y; Li X
J Ethnopharmacol; 2019 Jan; 228():110-122. PubMed ID: 30243827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
